NCT02750982 Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. Status COMPLETED Phase NA
NCT02714036 A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS) Status COMPLETED Phase PHASE1/PHASE2
NCT02710162 Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase EARLY_PHASE1
NCT02710110 Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase EARLY_PHASE1
NCT02675075 DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS Status COMPLETED Phase N/A
NCT02655614 A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT02645461 Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS Status COMPLETED Phase NA
NCT02623699 An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE3
NCT02611674 Methodology Study of Novel Outcome Measures to Assess Progression of ALS Status COMPLETED Phase N/A
NCT02590276 Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase NA
NCT02588807 Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis Status WITHDRAWN Phase PHASE1
NCT02582385 In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase N/A
NCT02572479 Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS) Status COMPLETED Phase N/A
NCT02532244 Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases Status COMPLETED Phase N/A